
Novacyt S.A.
EPA:ALNOV.PA
Overview | Financials
Company Name | Novacyt S.A. |
Symbol | ALNOV.PA |
Currency | EUR |
Price | 0.591 |
Market Cap | 41,740,143 |
Dividend Yield | 0% |
52-week-range | 0.497 - 1.59 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. James Martin McCarthy |
Website | https://www.novacyt.com |
An error occurred while fetching data.
About Novacyt S.A.
Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD